Keyphrases
Cervical Cancer
100%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
100%
Concurrent Chemotherapy
100%
Negative Lymph Nodes
100%
Chemotherapy
50%
Irradiation
50%
Survival Estimation
50%
Whole-body
25%
5-year Survival
25%
Cox Proportional Hazards Model
25%
Pelvis
25%
Distant Metastasis
25%
Radiation Dose
25%
Time Dose
25%
Associated Complications
25%
Prognostic Factors
25%
Concurrent Cisplatin
25%
Severe Complications
25%
Tumor Stage
25%
Survival Outcomes
25%
Overall Treatment Time
25%
Weekly Cisplatin
25%
Cause-specific Survival
25%
Recurrence Site
25%
Rectovaginal Fistula
25%
Colostomy
25%
Data Registry
25%
Rectal Stricture
25%
Medicine and Dentistry
Positron Emission Tomography
100%
Lymph Node
100%
Cervical Cancer
100%
Fluorodeoxyglucose
100%
Cisplatin
50%
Survival Estimate
50%
Overall Survival
25%
Proportional Hazards Model
25%
Pelvis
25%
Stricture
25%
Distant Metastasis
25%
Recurrent Disease
25%
Cancer Staging
25%
Prognostic Factor
25%
Rectovaginal Fistula
25%
Cause Specific Survival
25%
Colostomy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Uterine Cervix Cancer
100%
Fluorodeoxyglucose
100%
Cisplatin
33%
Overall Survival
16%
Distant Metastasis
16%
Recurrent Disease
16%
Cancer Staging
16%
Rectovaginal Fistula
16%
Cause Specific Survival
16%
Immunology and Microbiology
Lymph Node
100%
Positron Emission Tomography
100%
Pelvis
25%
Overall Survival
25%
Cancer Staging
25%
Cause Specific Survival
25%